California's insulin initiative offers path for other state drug manufacturing efforts
Medical Xpress
NOVEMBER 15, 2022
In a new 'Ideas and Opinions,' authors from Johns Hopkins Bloomberg School of Public Health analyze California's newly announced effort to manufacture insulin for its residents. The commentary is published in Annals of Internal Medicine.
Let's personalize your content